Ironwood [IRWD] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Ironwood Pharmaceuticals Inc.

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Ironwood Pharmaceuticals Inc. wins in 6 metrics, Haleon Plc - ADR wins in 13 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ironwood Pharmaceuticals Inc. Haleon Plc - ADR Better
P/E Ratio (TTM) 27.13 18.72 Haleon Plc - ADR
Price-to-Book Ratio -2.35 1.88 Haleon Plc - ADR
Debt-to-Equity Ratio -2.28 52.37 Haleon Plc - ADR
PEG Ratio -0.18 15.42 Haleon Plc - ADR
EV/EBITDA 8.67 33.08 Ironwood Pharmaceuticals Inc.
Profit Margin (TTM) 8.11% 15.11% Haleon Plc - ADR
Operating Margin (TTM) 13.74% 23.17% Haleon Plc - ADR
EBITDA Margin (TTM) 13.74% 23.17% Haleon Plc - ADR
Return on Equity -9.17% 10.27% Haleon Plc - ADR
Return on Assets (TTM) 19.85% 4.67% Ironwood Pharmaceuticals Inc.
Free Cash Flow (TTM) $127.01M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return 488.71% -16.01% Ironwood Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 2.24 3.78 Ironwood Pharmaceuticals Inc.
Enterprise Value $1.05B $122.54B Haleon Plc - ADR
EV/Revenue Ratio 3.53 8.23 Ironwood Pharmaceuticals Inc.
Gross Profit Margin (TTM) N/A 55.38% N/A
Revenue per Share (TTM) $2 $2 Haleon Plc - ADR
Earnings per Share (Diluted) $0.15 $0.50 Haleon Plc - ADR
Beta (Stock Volatility) 0.17 0.33 Ironwood Pharmaceuticals Inc.
Short % of Float 16.61% 0.43% Haleon Plc - ADR

Ironwood Pharmaceuticals Inc. vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

IRWD
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ironwood Pharmaceuticals Inc.1.10%12.16%3.07%9.50%2.79%-13.58%
Haleon Plc - ADR-0.66%2.02%1.23%-13.29%-7.73%-9.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ironwood Pharmaceuticals Inc.488.71%-66.76%-68.86%-65.27%-72.43%-62.79%
Haleon Plc - ADR-16.01%8.43%23.21%23.21%23.21%23.21%

Performance & Financial Health Analysis: Ironwood Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricIRWDHLN
Market Information
Market Cap i$617.99M$42.40B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,783,7326,594,249
90 Day Avg. Volume i2,608,5377,985,230
Last Close$3.69$9.07
52 Week Range$0.62 - $5.78$8.65 - $11.28
% from 52W High-36.16%-19.59%
All-Time High$17.76 (Jul 09, 2018)$11.42 (Jun 02, 2025)
% from All-Time High-79.22%-20.58%
Growth Metrics
Quarterly Revenue Growth-0.47%0.01%
Quarterly Earnings Growth-0.47%0.86%
Financial Health
Profit Margin (TTM) i0.08%0.15%
Operating Margin (TTM) i0.14%0.23%
Return on Equity (TTM) i-0.09%0.10%
Debt to Equity (MRQ) i-2.2852.37
Cash & Liquidity
Book Value per Share (MRQ)$-1.61$4.99
Cash per Share (MRQ)$1.32$0.15
Operating Cash Flow (TTM) i$127.04M$3.56B
Levered Free Cash Flow (TTM) i$111.57M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Ironwood Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricIRWD (Apr 24, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.1318.72
Forward P/E i2.7915.42
PEG Ratio i-0.1815.42
Price to Sales (TTM) i2.243.78
Price to Book (MRQ) i-2.351.88
Market Capitalization
Market Capitalization i$617.99M$42.40B
Enterprise Value i$1.05B$122.54B
Enterprise Value Metrics
Enterprise to Revenue i3.538.23
Enterprise to EBITDA i8.6733.08
Risk & Other Metrics
Beta i0.170.33
Book Value per Share (MRQ) i$-1.61$4.99

Financial Statements Comparison: Ironwood Pharmaceuticals Inc. vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIRWD (2025)HLN (2025)
Revenue/Sales i296.15M11.03B
Cost of Goods Sold iN/A3.95B
COGS % of Revenue i0.0%35.8%
Gross Profit iN/A7.08B
Gross Margin i0.0%64.2%
Research & Development i95.14M316.00M
Operating Income (EBIT) i118.76M2.41B
Operating Margin i40.1%21.9%
EBITDA i124.91M2.81B
EBITDA Margin i42.2%25.5%
Pre-Tax Income i70.03M2.15B
Pre-Tax Income % of Revenue i23.6%19.5%
Income Tax i46.01M472.00M
Income Tax % of Revenue i15.5%4.3%
Net Income (Profit) i24.02M1.68B
Profit Margin i8.1%15.2%

Balance Sheet & Liquidity Metrics

MetricIRWD (2025)HLN (2025)
Cash & Equivalents i215.46M1.26B
Total Current Assets i274.18M4.55B
Total Current Assets % of Revenue i92.6%41.3%
Total Current Liabilities i242.22M4.93B
Total Current Liabilities % of Revenue i81.8%44.7%
Long-Term Debt i394.87M7.75B
Long-Term Debt % of Revenue i133.3%70.2%
Total Shareholders Equity i-261.84M16.48B
Retained Earnings i-1.67B27.85B
Retained Earnings % of Revenue i-565.2%252.5%
Property, Plant & Equipment i9.34M1.00M

Cash Flow Statement Comparison

MetricIRWD (2025)HLN (2025)
Operating Cash Flow i130.69M2.19B
Operating Cash Flow % of Revenue i44.1%19.8%
Capital Expenditures i-34,000-322.00M
Free Cash Flow i127.01M2.22B
FCF Margin i42.9%20.1%
Debt Repayment i0-1.35B
Common Stock Repurchase iN/A-654.00M

Short Interest & Institutional Ownership Analysis

MetricIRWDHLN
Shares Short i17.90M19.28M
Short Ratio i5.912.14
Short % of Float i16.61%0.43%
Shares Outstanding i163.06M8.91B
Float Shares i125.58M8.86B
% Held by Insiders i3.05%0.01%
% Held by Institutions i92.07%12.74%
% Held by Public i4.88%87.25%

Dividend Analysis & Yield Comparison: Ironwood Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricIRWDHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025